In this regard, VEGF secreted by cancer cells is a well-recognized therapeutic target and several angiogenic inhibitors have been developed with the capability of also suppress self-renewal of CSCs leading to reduced tumor growth. This evidence concerns the gene VEGFA and neoplasm.